← Back to Search

Other

Technology-Driven Intervention for Cognitive Impairment (CI Wizard Trial)

N/A

Recruiting

Research Sponsored by HealthPartners Institute

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 24 months post index visit

Awards & highlights

CI Wizard Trial Summary

This trial aims to help early detect cognitive impairment with machine learning & clinical decision support tools, helping patients & caregivers with difficult decisions & improved quality of life.

Who is the study for?

This trial is for people aged 65 or older who visit a participating primary care clinic, have no prior diagnosis of cognitive impairment (CI), and show signs of CI based on specific tests. They must not have had chemotherapy for advanced cancer in the last year, be in hospice or palliative care.Check my eligibility

What is being tested?

The study is testing a new system called CI-CDS that uses machine learning to help doctors spot early signs of dementia. It's integrated into electronic health records and aims to improve detection and management of cognitive issues.See study design

What are the potential side effects?

Since this intervention involves technology rather than medication, traditional side effects are not applicable. However, there may be privacy concerns or potential stress related to increased monitoring.

CI Wizard Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 24 months post index visit

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 24 months post index visit

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 24 months post index visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

CI Diagnosis

Secondary outcome measures

Clinician Confidence

Healthcare Utilization Costs

CI Wizard Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: CI-CDSExperimental Treatment1 Intervention

In clinics randomized to the CI-CDS, the providers will be given the option to use the CI-CDS tool during eligible patient encounters.

Group II: Usual Care (UC)Active Control1 Intervention

In clinics randomized to UC, patients will receive usual care at their primary care visits over the accrual period (no intervention will be given).

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

HealthPartners InstituteLead Sponsor

186 Previous Clinical Trials

3,713,166 Total Patients Enrolled

8 Trials studying Dementia

3,491 Patients Enrolled for Dementia

National Institute on Aging (NIA)NIH

1,675 Previous Clinical Trials

28,017,884 Total Patients Enrolled

268 Trials studying Dementia

23,624,605 Patients Enrolled for Dementia

OCHIN, Inc.OTHER

21 Previous Clinical Trials

8,722,104 Total Patients Enrolled

Media Library

CI-CDS (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05723523 — N/A

Dementia Research Study Groups: CI-CDS, Usual Care (UC)

Dementia Clinical Trial 2023: CI-CDS Highlights & Side Effects. Trial Name: NCT05723523 — N/A

CI-CDS (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05723523 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this scientific experiment still accepting new participants?

"As per clinicaltrials.gov, this study is not currently recruiting patients; the trial was first advertised on March 1st 2023 and last updated February 2nd 2023. Fortunately, there are 901 other studies actively enrolling participants at present time."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment

2023. "A Technology-Driven Intervention to Improve Early Detection and Management of Cognitive Impairment". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05723523.

All > Dementia